9.56B4.3%
Total Revenue QoQ (USD) - Q3 '25

Sign up to access historical data

Sign up

Income Statement (USD)

Q3 '25 QoQ
Revenue 9.56B 4.3%
Gross Profit 6.48B 5.2%
Cost of Revenue 3.08B 2.4%
Operating expense 3.95B 12.4%
Net Income 3.22B 124.6%
EBITDA 5.91B 63.5%

Balance Sheet (USD)

Q3 '25 QoQ
Total Assets 90.1B 2.6%
Total Liabilities 80.5B 0.1%
Total Equity 9.62B 29.5%
Shares Outstanding 542M 0.2%

Cash Flow (USD)

Q3 '25 QoQ
Cash from operations 4.68B 105.4%
Cash from investing -414M 6.4%
Cash from financing -2.85B 6.7%

EPS

Only available for members.

Financial Highlights for Amgen in Q3 '25

Amgen reported a revenue of 9.56B, which is a 4.3% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.

Gross Profit stood at 6.48B, marking a 5.2% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.

Cost of Revenue was 3.08B, a 2.4% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.

Operating Expenses for this period were 3.95B, showing a 12.4% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.

Net Income for the quarter was 3.22B, showing a 124.6% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.

The company's EBITDA for the quarter was 5.91B, showing a 63.5% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.

It was a positive quarter for Amgen with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.